DENISE WOLFE: Open Payments
NPI 1568177004 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 16 payments from 10 companies in 2025. Trend: 2023 $195 · 2024 $46 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Dexcom, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| Corcept Therapeutics | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| TOLMAR, INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REXULTI, Dexcom G6 Transmitter, Korlym, JARDIANCE, GVOKE HYPOPEN, Ozempic, QULIPTA, UBRELVY.
Industry payments across SC — which companies pay providers there.
